Belvedere Trading
DMTK

Belvedere Trading’s DermTech, Inc. Common Stock DMTK Stock Holding History

Belvedere Trading’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,408
Closed -$12.5K – 1208
2023
Q1 		$12.5K Buy
+3,408
New +$14.4K ﹤0.01% 738

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Belvedere Trading's DMTK Position: Q2 2023 in Review

Belvedere Trading sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 3,408 shares — an estimated $12.5K sold.

Belvedere Trading first reported a position in DMTK in Q1 2023 and held it in 1 quarter. The position peaked at $12.5K in Q1 2023. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

  • Belvedere Trading reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Belvedere Trading sold 3,408 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $12.5K.
  • Belvedere Trading first reported a position in DermTech, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Belvedere Trading's DermTech, Inc. Common Stock position peaked at $12.5K in Q1 2023.
  • 85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Belvedere Trading's 13F filing for Q2 2023, filed 8 Aug 2023.